This site is part of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
The MENA region is rapidly developing and extremely diverse, spanning both countries at the cutting-edge of innovation and technology as well as emerging economies. According to Trade Arabia, the territory’s pharmaceutical market stands to grow to USD 60 billion by 2025, driven by significant growth in the UAE as well as in North African giants Egypt and Algeria.
Egypt’s pharmaceutical market is among the most attractive in the MENA region. With the reforming economic and regulatory environment, there has been an increase in interest and investment from multinational pharmaceutical companies to enter this market. Egypt’s healthcare market is set for a period of transformation as the country is attempting to achieve universal healthcare access through the implementation of a comprehensive health insurance system.
Gypto Pharma - Middle East biggest pharma city in Egypt
Gypto Pharma, also known as the Medicine City, inaugurated in April 2021 and is covering 180,000 sqm. The city is one of the largest of its kind in the Middle East as it included 160 manufacturing lines and 150 types of medicines by 2023.
Gypto Pharma uses the latest technologies and automated machines to ensure production is of the highest quality. This will increase cooperation between the state and the private sector to transform Egypt into a regional center for the pharmaceutical industry in the Middle East.
